Patents by Inventor David Shields

David Shields has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7956104
    Abstract: A pourable opaque centerport for solid propellant rocket motors and method for applying the same are disclosed. The pourable centerport inhibitor for solid propellant rocket motors has a curing system that includes a prepolymer and a curing agent. The prepolymer and the curing agent are combined to form a pourable polymeric binder that cures into an amorphous solid. The pourable centerport inhibitor also includes an opaque agent. The pourable centerport inhibitor may also include a plasticizer. The plasticizer, the prepolymer, and the curing agent are preferably the same type that is in the solid propellant with which it will be used in conjunction.
    Type: Grant
    Filed: February 24, 2003
    Date of Patent: June 7, 2011
    Assignee: Alliant Techsystems Inc.
    Inventors: Matthew S. Scott, Carl Shanholtz, David Shields, Dayne Lancaster
  • Patent number: 7753928
    Abstract: A space occupying device for deployment within a patient's stomach and methods of deploying and removing the device. The device includes an expandable member and fasteners, such as sutures, that extend to least partially through the patient's stomach wall, and that anchor the device with the patient's stomach. The device can be deployed and/or removed through transesophageal approaches and/or through a combination of transesophageal and transabdominal approaches.
    Type: Grant
    Filed: April 14, 2005
    Date of Patent: July 13, 2010
    Assignee: Satiety, Inc.
    Inventors: Roger de la Torre, J. Stephen Scott, Thomas A. Howell, George D. Hermann, David Shields, Robert T. Chang, Neil Holmgren, David Willis
  • Publication number: 20090139205
    Abstract: A pourable opaque centerport for solid propellant rocket motors and method for applying the same are disclosed. The pourable centerport inhibitor for solid propellant rocket motors has a curing system that includes a prepolymer and a curing agent. The prepolymer and the curing agent are combined to form a pourable polymeric binder that cures into an amorphous solid. The pourable centerport inhibitor also includes an opaque agent. The pourable centerport inhibitor may also include a plasticizer. The plasticizer, the prepolymer, and the curing agent are preferably the same type that is in the solid propellant with which it will be used in conjunction.
    Type: Application
    Filed: February 24, 2003
    Publication date: June 4, 2009
    Inventors: Matthew S. Scott, Carl Shanholtz, David Shields, Dayne Lancaster
  • Publication number: 20070270353
    Abstract: The present invention is direct to a method of producing analgesia in a mammalian subject. The method includes administering to the subject an omega conopeptide, preferably ziconotide, in combination with an analgesic selected from the group consisting of morphine, bupivicaine, clonidine, hydromorphone, baclofen, fentanyil, buprenorphine, and sufentanil, or its pharmaceutically acceptable salts thereof, wherein the ?-conopeptide retains its potency and is physically and chemically compatible with the analgesic compound. A preferred route of administration is intrathecal administration, particularly continuous intrathecal infusion. The present invention is also directed to a pharmaceutical formulation comprising an omega conopeptide, preferably ziconotide, an antioxidant, in combination with an analgesic selected from the group consisting of morphine, bupivicaine, clonidine, hydromorphone, baclofen, fentanyl, buprenorphine, and sufentanil.
    Type: Application
    Filed: July 31, 2007
    Publication date: November 22, 2007
    Inventors: DAVID ELLIS, George Miljanich, David Shields
  • Publication number: 20070269528
    Abstract: The present invention is direct to a method of producing analgesia in a mammalian subject. The method includes administering to the subject an omega conopeptide, preferably ziconotide, in combination with an analgesic selected from the group consisting of morphine, bupivicaine, clonidine, hydromorphone, baclofen, fentanyil, buprenorphine, and sufentanil, or its pharmaceutically acceptable salts thereof, wherein the ?-conopeptide retains its potency and is physically and chemically compatible with the analgesic compound. A preferred route of administration is intrathecal administration, particularly continuous intrathecal infusion. The present invention is also directed to a pharmaceutical formulation comprising an omega conopeptide, preferably ziconotide, an antioxidant, in combination with an analgesic selected from the group consisting of morphine, bupivicaine, clonidine, hydromorphone, baclofen, fentanyl, buprenorphine, and sufentanil.
    Type: Application
    Filed: July 31, 2007
    Publication date: November 22, 2007
    Inventors: David Ellis, George Miljanich, David Shields
  • Publication number: 20070066386
    Abstract: The gaming system with phone card payout is a system for playing a video game using a smart card. A dispensing station includes a smart card reader, a bill acceptor and a phone card dispenser. The bill acceptor reads the monetary value of currency inserted in the machine and stores the monetary value on a smart card. The stored monetary value can be used to either purchase prepaid phone cards at the dispensing station or to play video games at an establishment hosting the dispensing station. The video games at the establishment are equipped with smart card readers. Logic in the video games verifies that the smart card monetary value was purchased at the hosting establishment and accepts the monetary value from a verified smart card for playing the video game. Video game credits accumulated on the game may be transferred back to the smart card.
    Type: Application
    Filed: September 21, 2005
    Publication date: March 22, 2007
    Inventor: David Shields
  • Patent number: 7033373
    Abstract: A space occupying device for deployment within a patient's stomach and methods of deploying and removing the device. The device includes an expandable member and fasteners, such as sutures, that extend to least partially through the patient's stomach wall, and that anchor the device with the patient's stomach. The device can be deployed and/or removed through transesophageal approaches and/or through a combination of transesophageal and transabdominal approaches.
    Type: Grant
    Filed: March 23, 2001
    Date of Patent: April 25, 2006
    Assignee: Satiety, Inc.
    Inventors: Roger de la Torre, J. Stephen Scott, Thomas A. Howell, George D. Hermann, David Shields, Robert T. Chang, Neil Holmgren, David Willis
  • Publication number: 20050192615
    Abstract: A space occupying device for deployment within a patient's stomach and methods of deploying and removing the device. The device includes an expandable member and fasteners, such as sutures, that extend to least partially through the patient's stomach wall, and that anchor the device with the patient's stomach. The device can be deployed and/or removed through transesophageal approaches and/or through a combination of transesophageal and transabdominal approaches.
    Type: Application
    Filed: April 14, 2005
    Publication date: September 1, 2005
    Inventors: Roger Torre, J. Scott, Thomas Howell, George Hermann, David Shields, Robert Chang, Neil Holmgren, David Willis
  • Publication number: 20050192218
    Abstract: The present invention is direct to a method of producing analgesia in a mammalian subject. The method includes administering to the subject an omega conopeptide, preferably ziconotide, in combination with an analgesic selected from the group consisting of morphine, bupivicaine, clonidine, hydromorphone, baclofen, fentanyil, buprenorphine, and sufentanil, or its pharmaceutically acceptable salts thereof, wherein the ?-conopeptide retains its potency and is physically and chemically compatible with the analgesic compound. A preferred route of administration is intrathecal administration, particularly continuous intrathecal infusion. The present invention is also directed to a pharmaceutical formulation comprising an omega conopeptide, preferably ziconotide, in combination with an analgesic selected from the group consisting of morphine, bupivicaine, clonidine, hydromorphone, baclofen, fentanyl, buprenorphine, and sufentanil.
    Type: Application
    Filed: October 1, 2004
    Publication date: September 1, 2005
    Inventors: David Ellis, George Miljanich, David Shields
  • Publication number: 20050056000
    Abstract: A system for draining fuel from the combustion chamber of a gas turbine engine in the event of a false start includes associated passageways and a straight through flow pilot air actuated poppet valve. The valve is normally open and actuated by the pilot air to close off the combustion chamber from the drain. A return spring biases the valve to open upon release of pilot air pressure acting on the valve. The valve housing has a piston section with a pilot air chamber and a section defining the passageways for the drain. The drain passageway extends along a straight path at an oblique angle to a piston axis along which a piston actuator moves in response to the return spring and/or the pilot air pressure. The valve also includes a position feedback system for detecting the state of the valve.
    Type: Application
    Filed: July 14, 2004
    Publication date: March 17, 2005
    Inventors: Harvey Jansen, David Shields
  • Publication number: 20020055757
    Abstract: A space occupying device for deployment within a patient's stomach and methods of deploying and removing the device. The device includes an expandable member and fasteners, such as sutures, that extend to least partially through the patient's stomach wall, and that anchor the device with the patient's stomach. The device can be deployed and/or removed through transesophageal approaches and/or through a combination of transesophageal and transabdominal approaches.
    Type: Application
    Filed: March 23, 2001
    Publication date: May 9, 2002
    Inventors: Roger de la Torre, J. Stephen Scott, Thomas A. Howell, George D. Hermann, David Shields, Robert T. Chang, Neil Holmgren, David Willis